Bishal Gyawali, Associate Professor at Queen’s University, shared a post on LinkedIn about a recent article he and colleagues authored:
“We’ve just published in BMJ Oncology an important global oncology paper studying the perceptions of Indian oncologists regarding FDA Approval status, International and resource-stratified guidelines, and national and institutional practices, as well as personal choices regarding treatment choices in cancer.
I think the results are fascinating.”
Title: Qualitative study of oncologists’ perceptions on the US Food and Drug Administration approval status and clinical practice guidelines and their impact on local practice patterns in India
Authors: Soumitra Datta, Varuna Sharma, Arnab Mukherjee, Sanjit Agrawal, Bhawna Sirohi, Bishal Gyawali
Read the Full Article in BMJ Oncology.
More posts featuring Bishal Gyawali on OncoDaily.